Intervene Immune

United States
Torrance, California, United States

Company profile

Intervene Immune company profile

Intervene Immune offer innovative treatments for the regeneration of the thymus and the aging of the immune system at Intervene Immune. They treat foreign invaders by educating bone marrow-derived cells to become the T cells that carry out cellular immune functions and protect from foreign invaders such as bacteria and viruses.

Business identity

Operating status
Active
Company type
For Profit
Employee range
51-100 employees
Revenue range
$0-$1M
Founded
2013-01-01, Year

Headquarters

Country code
US
Continent
North America

Capital profile

Funding and company signals

Funding rounds
1
Last funding
Convertible Note / 2021-10-01
Investors
1
Articles
3

Categories and groups

Founders and investors

Investors

Longevitytech.fund